ALTO-202

N/A

Report date: 2024/04/12 11:54:29

NME

Base Information

Drug NameALTO-202

Drug Alias NameALTO-202

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 antagonists

TargetsGlutamate [NMDA] receptor subunit epsilon 2

Therapy Area/IndicationsStress Disorders, Post-TraumaticDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsStress Disorders, Post-Traumatic

ATC CodeN/A